Condition: Eosinophilic Granulomatosis With Polyangiitis · Churg-Strauss Syndrome · Sponsor: University of Pennsylvania
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare immune system disorder that causes asthma, an excessive number of eosinophils (a type of white blood cell) in the blood, and the inflammation of blood vessels, or vasculitis. In order to properly treat EGPA, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of this disease in people with EGPA.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| University of California San Diego | San Diego, California, United States | Completed |
| National Jewish Health | Denver, Colorado, United States | Completed |
| Brigham and Women's Hospital | Boston, Massachusetts, United States | Completed |
| Mayo Clinic | Rochester, Minnesota, United States | Completed |
| Cleveland Clinic Foundation | Cleveland, Ohio, United States | Completed |
| University of Pennsylvania | Philadelphia, Pennsylvania, United States | Completed |
| University of Pittsburgh | Pittsburgh, Pennsylvania, United States | Completed |
| University of Utah | Salt Lake City, Utah, United States | Completed |
| St. Joseph's Healthcare | Hamilton, Ontario, Canada | Recruiting |
| Mount Sinai Hospital | Toronto, Ontario, Canada | Completed |
| medius KLINIK KIRCHHEIM | Kirchheim unter Teck, Germany | Recruiting |
| AOU Meyer IRCCS | Florence, Italy | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00315380